Search Results 2061-2070 of 16523 for استخدام حبوب منع الحمل

  1. A Study to Evaluate Pomalidomide to Treat Bleeding in Hereditary Hemorrhagic Telangiectasia (HHT) - Mayo Clinic

    Females of childbearing potential (FCBP)† must adhere to the pregnancy testing schedule mandated by the POMALYST REMS® program. ... The use of octreotide or ...

  2. Publications - Pierre Noel, M.D. - Mayo Clinic

    ... prevention of graft-versus-host disease with ... Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell ...

  3. Squamous Cell Carcinoma Of The Skin Clinical Trials - Mayo Clinic Research

    Drugs used in chemotherapy, such as cisplatin, work in different ways to ... tablets together with cetuximab as recommended by the label: Arm A - whole tablets ...

  4. Biomedical Ethics Research Program - Overview

    Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below. ... A single copy of these materials may be reprinted ...

  5. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

    Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has ...

  6. A Study to Evaluate the Safety and Effectiveness of Antithrombotics to Treat Hospitalized COVID-19 Patients - Mayo Clinic

    Site IRB. Scottsdale/Phoenix, Arizona: 20-012572 ... prevention of adverse outcomes in COVID-19 positive inpatients ... Pregnancy. Eligibility last ...

  7. Doctors and departments - Mayo Clinic

    Research. Mayo Clinic doctors and scientists are studying new ways to diagnose and treat vulvar cancer. Cancer research is conducted in coordination with ...

  8. Multiple myeloma - Symptoms and causes - Mayo Clinic

    Learn more about Mayo Clinic's use of data. ... But the body can't use these antibodies, called monoclonal proteins or M proteins. ... There's no way to prevent ...

  9. ADSTILADRIN Early Utilization and Outcomes in the Real World Setting in the United States - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. A Study to Determine the Effectiveness and Safety of Luspatercept in Patients with Myelodysplastic/ Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis - Mayo Clinic

    However, the FDA has allowed the use of this drug combination in this research study. Participation eligibility. Participant eligibility includes age, gender, ...